09/2009 - Državni zavod za intelektualno vlasništvo
09/2009 - Državni zavod za intelektualno vlasništvo
09/2009 - Državni zavod za intelektualno vlasništvo
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
3548 HR - Patenti - Hrvatski glasnik <strong>intelektualno</strong>g vlasništva 16, 20<strong>09</strong>, 9, 3373 – 3601<br />
Podnositelj europske MKP Broj objave europske Naziv izuma<br />
prijave patenta<br />
prijave patenta<br />
(71) (51) (97) (54)<br />
Emotional Brain B.V., NL A61K 31/496 (2006.01)<br />
A61K 31/568 (2006.01)<br />
EP 2086544 *<br />
A61K 31/519 (2006.01)<br />
A61P 15/00 (2006.01)<br />
Emotional Brain B.V., NL A61K 31/496 (2006.01)<br />
A61K 31/519 (2006.01)<br />
A61K 31/568 (2006.01)<br />
Emotional Brain B.V., NL A61K 31/519 (2006.01)<br />
A61K 31/496 (2006.01)<br />
A61P 15/00 (2006.01)<br />
A61K 31/568 (2006.01)<br />
ErgoNex Pharma GmbH, CH A61K 31/48 (2006.01)<br />
A61K 31/00 (2006.01)<br />
A61P 9/10 (2006.01)<br />
A61P 9/08 (2006.01)<br />
Eureka Group s.r.l., IT C02F 3/22 (2006.01)<br />
C02F 11/02 (2006.01)<br />
Eötvös Lorand University, HU C07K 14/705 (2006.01)<br />
C12N 15/85 (2006.01)<br />
A01K 67/027 (2006.01)<br />
F. Hoffmann-Roche AG, CH C07D 237/28 (2006.01)<br />
C07D 237/08 (2006.01)<br />
C07D 237/26 (2006.01)<br />
A61K 31/502 (2006.01)<br />
F.HOFFMANN-LA ROCHE AG, CH C07K 16/18 (2006.01)<br />
A61K 39/395 (2006.01)<br />
A61K 9/00 (2006.01)<br />
A61K 47/00 (2006.01)<br />
Fachhochschule Dortmund, DE B29C 33/02 (2006.01)<br />
B29C 33/40 (2006.01)<br />
B29C 70/88 (2006.01)<br />
Farco-Pharma GmbH, DE A61K 31/728 (2006.01)<br />
A61K 31/737 (2006.01)<br />
A61P 13/10 (2006.01)<br />
Finney, Ian Antony, GB B60R 19/03 (2006.01)<br />
B60R 21/34 (2006.01)<br />
Finzelberg GmbH & Co. KG, DE A61K 36/185 (2006.01)<br />
A61P 15/10 (2006.01)<br />
Fisher-Rosemount Systems, Inc., US G05B 19/418 (2006.01)<br />
G05B 23/02 (2006.01)<br />
Foldrx Pharmaceuticals, Inc., US C12N 5/00 (2006.01)<br />
G01N 33/567 (2006.01)<br />
FORDE, Gareth Michael, AU B01D 15/08 (2006.01)<br />
B01J 39/26 (2006.01)<br />
C08L 33/10 (2006.01)<br />
B01D 15/38 (2006.01)<br />
B01J 41/20 (2006.01)<br />
G01N 30/02 (2006.01)<br />
B01D 15/42 (2006.01)<br />
C08F 20/06 (2006.01)<br />
Fraunhofer-Gesellschaft zur Förderung A23J 1/14 (2006.01)<br />
der Angewandten Forschung e.V., DE<br />
Freixas Vila, Ramon, ES H02K 53/00 (2006.01)<br />
FujiFilm Electronic Materials USA, Inc., G03F 7/20 (2006.01)<br />
US<br />
Functional Genetics, Inc., US A61K 35/00 (2006.01)<br />
C07K 16/00 (2006.01)<br />
G. E. W. (EC) Limited, GB B41F 23/00 (2006.01)<br />
B41F 23/04 (2006.01)<br />
B41M 7/00 (2006.01)<br />
GANTAR, Mark D., US A61B 17/132 (2006.01)<br />
Genelux Corporation, US C12N 7/04 (2006.01)<br />
C12N 15/863 (2006.01)<br />
C07K 14/07 (2006.01)<br />
A61K 35/76 (2006.01)<br />
A61K 39/285 (2006.01)<br />
A61K 48/00 (2006.01)<br />
GENENTECH, INC., US A61K 38/48 (2006.01)<br />
A61M 25/00 (2006.01)<br />
GENENTECH, INC., US C07K 16/28 (2006.01)<br />
GENENTECH, INC., US A61K 39/395 (2006.01)<br />
GENENTECH, INC., US C12Q 1/68 (2006.01)<br />
EP 2086545 *<br />
EP 2086548 *<br />
EP 2<strong>09</strong>1537 *<br />
EP 2089329 *<br />
EP 2<strong>09</strong>7444 *<br />
EP 1904455 *<br />
EP 2<strong>09</strong>4729 *<br />
EP 2<strong>09</strong>9596 *<br />
EP 2<strong>09</strong>9462 *<br />
EP 2<strong>09</strong>9653 *<br />
EP 2<strong>09</strong>4285 *<br />
EP 2<strong>09</strong>5195 *<br />
EP 2087<strong>09</strong>7 *<br />
EP 2<strong>09</strong>1623 *<br />
EP 2040563 *<br />
EP 2<strong>09</strong>1139 *<br />
EP 2089774 *<br />
EP 2<strong>09</strong>4282 *<br />
EP 2089228 *<br />
EP 2<strong>09</strong>9366 *<br />
EP 2<strong>09</strong>7517 *<br />
EP 2086571 *<br />
EP 2087006 *<br />
EP 2089059 *<br />
EP 2089540 *<br />
USE OF TESTOSTERONE AND A 5-HT1A AGONIST<br />
IN THE TREATMENT OF SEXUAL DYSFUNCTION<br />
USE OF 3-ALPHA-ANDROSTANEDIOL, OPTIONALLY<br />
IN COMBINATION WITH A PDE5 INHIBITOR, IN THE<br />
TREATMENT OF SEXUAL DYSFUNCTION<br />
USE OF 3-ALPHA-ANDROSTANEDIOL, OPTIONALLY<br />
IN COMBINATION WITH A 5-HT1A AGONIST, IN THE<br />
TREATMENT OF SEXUAL DYSFUNCTION<br />
PHARMACEUTICAL COMPOSITIONS FOR THE<br />
TREATMENT OF CAPILLARY ARTERIOPATHY<br />
DEEP-SHAFT DEPURATOR PLANT COMPRISING<br />
TWO AIR-LIFTS<br />
TRANSGENIC ANIMAL WITH ENHANCED IMMUNE<br />
RESPONSE AND METHOD FOR THE PREPARATION<br />
THEREOF<br />
PYRIDAZINE DERIVATIVES<br />
ABETA ANTIBODY PARENTERAL FORMULATION<br />
MOULD TOOL FOR THE DE NOVO MOULDING OR<br />
REMOULDING OF COMPONENTS MADE FROM<br />
THERMALLY INFLUENCEABLE MATERIALS<br />
PHARMACEUTICAL PREPARATION FOR THE<br />
TREATMENT OF INFLAMMATORY DISEASES OF<br />
THE UROGENITAL TRACT<br />
ENERGY ABSORBING STRUCTURES<br />
SPECIAL EXTRACT, AND USE THEREOF FOR THE<br />
PREVENTION OF CYCLIC GUANOSINE<br />
MONOPHOSPHATE (CGMP) DECOMPOSITION<br />
METHOD AND SYSTEM FOR DETECTING FAULTS IN<br />
A PROCESS PLANT<br />
CELLS EXPRESSING ALPHA-SYNUCLEIN AND USES<br />
THEREFOR<br />
MATERIALS, METHODS AND SYSTEMS FOR<br />
PURIFICATION AND/OR SEPERATION<br />
HIGHLY CONCENTRATED PLANT PROTEIN<br />
PREPARATION AND METHOD FOR PRODUCING<br />
THE SAME<br />
ROTOR FOR MAGNETIC MOTOR<br />
DEVICE MANUFACTURING PROCESS UTILIZING A<br />
DOUBLE PATTERING PROCESS<br />
ANTI-TSG101 ANTIBODIES AND THEIR USES FOR<br />
TREATMENT OF VIRAL INFECTIONS<br />
COOLING SYSTEM FOR INK CURING APPARATUS<br />
TOURNIQUET SYSTEM<br />
MODIFIED VACCINIA VIRUS STRAINS FOR USE IN<br />
DIAGNOSTIC AND THERAPEUTIC METHODS<br />
TISSUE PLASMINOGEN ACTIVATOR VARIANT USES<br />
ANTI-NOTCH3 AGONIST ANTIBODIES AND THEIR<br />
USE IN THE TREATMENT OF NOTCH3-RELATED<br />
DISEASES<br />
METHOD FOR TREATING AGE-RELATED MACULAR<br />
DEGENERATION<br />
GENETIC VARIATIONS ASSOCIATED WITH TUMORS<br />
ISSN 1331-2030